Article

A neuroimmunological perspective on anxiety disorders

University Department of Psychiatry, Faculty of Medicine, University of Southampton, Southampton, UK.
Human Psychopharmacology Clinical and Experimental (Impact Factor: 2.19). 01/2012; 27(1):6-14. DOI: 10.1002/hup.1259
Source: PubMed

ABSTRACT

Research into psychoneuroimmunology has led to substantial advances in our understanding of the reciprocal interactions between the central nervous system and the immune system in neuropsychiatric disorders. To date, the presence of inflammatory responses and the crucial role of cytokines in major depression have been addressed in numerous studies. However, neuroinflammatory hypotheses in anxiety disorders have been studied less extensively than in major depression. There is a high research need for better understanding of both the heterogeneous role of specific cytokines in the control of anxious states and in different anxiety disorders and of the immunomodulating effects of antidepressants on anxiety.
Relevant literature was identified through a search of MEDLINE via PubMed. We discuss recent research on neuroimmunology in anxiety and make methodological recommendations for future investigation of neuroinflammatory hypotheses in anxiety disorders.
Some accumulating evidence has indicated modulatory effects of cytokines on neuronal communication and anxiety; however, research has not revealed consistent reproducible findings.
The availability of inflammatory biomarkers may provide an opportunity to identify patients via specific pathophysiological processes and to monitor therapeutic responses within relevant pathways. Further understanding of the neuroimmunological mechanisms to untangle the reciprocal associations between inflammation and anxiety is warranted.

Full-text preview

Available from: onlinelibrary.wiley.com
    • "Increases in state anxiety have also been reported by a few groups (Reichenberg et al., 2001), including our own (Grigoleit et al., 2011; Wegner et al., 2014; Karshikoff et al., 2015), but have received less attention despite possible clinical implications for the pathophysiology of stress-related disorders and neuropsychiatric conditions. There is evidence supporting a possible role of inflammatory processes in the pathophysiology of clinical anxiety (Pitsavos et al., 2006; O'Donovan et al., 2010; Vogelzangs et al., 2013; Liukkonen et al., 2011, for review, see Hou and Baldwin, 2012), as well as altered immune responses to infection, immune stimulation or psychological stress in stress-related conditions (for review, see Godbout and Glaser, 2006). Findings in experimental animals support the relevance of afferent immune-to-brain communication for anxiety-like behavior (Bassi et al., 2012; Prager et al., 2013; for review see Goehler et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lipopolysaccharide (LPS) administration is a well-established model to assess afferent immune-to-brain communication and behavioral aspects of inflammation. Nevertheless, only few studies in comparatively small samples have assessed state anxiety as a psychological component of sickness behavior despite possible clinical implications for the pathophysiology of neuropsychiatric conditions. Thus, the goal of the present analyses carried out in a large, pooled dataset from two independent study sites was to analyze the state anxiety response to LPS administration and to investigate predictors (i.e., cytokine changes; pre-existing anxiety and depression symptoms assessed with the Hospital Anxiety and Depression Scale) of the LPS-induced state anxiety changes at different time points after LPS administration. Data from 186 healthy volunteers who participated in one of six randomized, placebo-controlled human studies involving intravenous administration of LPS at doses of 0.4-0.8 ng/kg body weight were combined. State anxiety as well as circulating interleukin (IL)-6, tumor necrosis factor (TNF)-α and IL-10 concentrations were significantly increased 2h and 3h after LPS administration, with a peak at 2h, and returned to baseline 6h after administration. Greater changes in IL-6 from baseline to 3h after LPS administration significantly and independently predicted a more pronounced LPS-induced state anxiety response. In addition, higher pre-existing subclinical anxiety symptoms significantly predicted a lower increase in state anxiety 3h and 6h after LPS-administration, which was mediated by TNF-α changes. In conclusion, our findings give additional support for a putative role of inflammatory mechanisms in the pathophysiology of stress-related and anxiety disorders and give new insight on the potential role of pre-existing subclinical affective symptoms.
    No preview · Article · Jan 2016 · Brain Behavior and Immunity
  • Source
    • "2012 ; Vervliet et al . 2013 ) ; unrelenting and unmanaged anxiety is certainly not without health risks ( Baganz and Blakely 2013 ; Hou and Baldwin 2012 ; Kemp and Quintana 2013 ) . In the following sections , we review four fundamental fear relapse phenomena : renewal , spontaneous recovery , reacquisition , and reinstatement . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Whereas fear memories are rapidly acquired and enduring over time, extinction memories are slow to form and are susceptible to disruption. Consequently, behavioral therapies that involve extinction learning (e.g., exposure therapy) often produce only temporary suppression of fear and anxiety. This review focuses on the factors that are known to influence the relapse of extinguished fear. Several phenomena associated with the return of fear after extinction are discussed, including renewal, spontaneous recovery, reacquisition, and reinstatement. Additionally, this review describes recent work, which has focused on the role of psychological stress in the relapse of extinguished fear. Recent developments in behavioral and pharmacological research are examined in light of treatment of pathological fear in humans.
    Full-text · Article · Sep 2014 · ILAR journal / National Research Council, Institute of Laboratory Animal Resources
  • Source
    • "Experimental and clinical studies have described the involvement of cytokines signaling in the central nervous system (CNS), leading to neurochemical, neuroendocrine, and behavioral changes [2] [6] [18] [28]. Interferon-gamma (IFN-␥) is a T-helper type 1 (Th1) cytokine that has been associated with early immune-mediated viral and antitumor activities, and later adaptive immune responses [1] [19]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A series of evidence suggests that interferon-gamma (IFN-γ) plays an important role in central nervous system (CNS) functions. However, previous studies have obtained inconsistent results regarding the role of IFN-γ in modulating emotion-related behaviors. The present study aimed to evaluate the behavioral profile of IFN-γ knockout (K.O.) mice in models of anxiety and depression. Male C57Bl6 wild type (WT) or IFN-γ K.O. mice were submitted to the following tests: contextual fear conditioning (CFC), elevated plus maze (EPM), open field (OF) and forced swimming test (FST). To explore the possible neurobiological mechanisms involved, we also assessed hippocampal neurogenesis by means of hippocampal doublecortin expression, and the levels of Brain-Derived Neurothophic Factor (BDNF) and Nerve Growth Factor (NGF) in the hippocampus and prefrontal cortex. Our results suggested that IFN-γ K.O. mice exhibited an anxiogenic profile in CFC, EPM and OF tests. In FST, the K.O. group spent more time immobile than the WT group. The number of doublecortin positive cells was reduced in the dentate gyrus, and the expression of NGF was down regulated in the prefrontal cortex of IFN-γ K.O. mice. Our results suggest that IFN-γ is involved in CNS plasticity, contributing to the modulation of anxiety e depressive states.
    Full-text · Article · Jun 2014 · Neuroscience Letters
Show more